nach oben

Langenbeck's Archives of Surgery

Erschienen in:

18.11.2017 | REVIEW ARTICLE

Preoperative optimization for major hepatic resection

verfasst von: Sarah Walcott-Sapp, Kevin G. Billingsley

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Major hepatic resections are performed for primary hepatobiliary malignancies, metastatic disease, and benign lesions. Patients with chronic liver disease, including cirrhosis and steatosis, are at an elevated risk of malnutrition and impaired strength and exercise capacity, deficits which cause increased risk of postoperative complications and mortality. The aims of this report are to discuss the pathophysiology of changes in nutrition, exercise capacity, and muscle strength in patient populations likely to require major hepatectomy, and review recommendations for preoperative evaluation and optimization.

Methods

Nutritional and functional impairment in preoperative hepatectomy patients, especially those with underlying liver disease, have a complex and multifactorial physiologic basis that is not completely understood.

Results

Recognition of malnutrition and compromised strength and exercise tolerance preoperatively can be difficult, but is critical in providing the opportunity to intervene prior to major hepatic resection and potentially improve postoperative outcomes. There is promising data on a variety of nutritional strategies to ensure adequate intake of calories, proteins, vitamins, and minerals in patients with cirrhosis and reduce liver size and degree of fatty infiltration in patients with hepatic steatosis. Emerging evidence supports structured exercise programs to improve exercise tolerance and counteract muscle wasting.

Conclusions

The importance of nutrition and functional status in patients indicated for major liver resection is apparent, and emerging evidence supports structured preoperative preparation programs involving nutritional intervention and exercise training. Further research is needed in this field to develop optimal protocols to evaluate and treat this heterogeneous cohort of patients.

Weinmann A, Braga M, Carli F, Higashiguchi T et al (2017) ESPEN guideline: clinical nutrition in surgery. Clin Nut 36(3):623–650. https://doi.org/10.1016/j.clnu.2017.02.013 CrossRef

Sungurtekin H, Sungurtekin U, Balci C, Zencir M, Erdem E (2004) The influence of nutritional status on complications after major intraaabdominal surgery. J Am Coll Nutr 23(3):227–232. https://doi.org/10.1080/07315724.2004.10719365 PubMedCrossRef

Dempsey DT, Mullen J, Buzby GP (1988) The link between nutritional status and clinical outcome: can nutritional intervention modify it? Am J Clin Nutr 47(2 Suppl):352–356PubMedCrossRef

Evans DC, Martindale R, Kiraly LN, Jones CM (2013) Nutrition optimization prior to surgery. Nutr Clin Pract 29(1):10–21. https://doi.org/10.1177/0884533613517006 PubMedCrossRef

Bozzetti F (2002) Rationale and indications for preoperative feeding of malnourished surgical cancer patients. Nutrition 18(11/12):953–959. https://doi.org/10.1016/S0899-9007(02)00988-7 PubMedCrossRef

Gallagher-Allred CR, Voss A, Finn SC, McCamish MA (1996) Malnutrition and clinical outcomes: the case for medical nutrition therapy. J Am Diet Assoc 96(4):361–366. https://doi.org/10.1016/S0002-8223(96)00099-5 PubMedCrossRef

Pichard C, Kyle U, Morabia A, Perrier A, Vermeulen B, Unger P (2004) Nutritional assessment: lean body mass depletion at hospital admission is associated with an increased length of stay. Am J Clin Nutr 79(4):613–618PubMedCrossRef

Gianotti L, Braga M, Nespoli L et al (2002) A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 122(7):1763–1770. https://doi.org/10.1053/gast.2002.33587 PubMedCrossRef

Gustafsson UO, Oppelstrup H, Thorell A et al (2016) Adherence to the ERAS protocol is associated with 5-year survival after colorectal surgery: a retrospective cohort study. World J Surg 40(7):1741–1747. https://doi.org/10.1007/s00268-016-3460-y PubMedCrossRef

10.

Horowitz M, Neeman E, Sharon E (2015) Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat Rev Clin Oncol 12(4):213–226. https://doi.org/10.1038/nrclinonc.2014.224 PubMedPubMedCentralCrossRef

11.

Toh SY, Zarshenas N, Jorgensen J (2009) Prevalence of nutrient deficiencies in bariatric patients. Nutrition 25(11-12):1150–1156. https://doi.org/10.1016/j.nut.2009.03.012 PubMedCrossRef

12.

Wells JCK (2013) Obesity as malnutrition: the dimensions beyond energy balance. Eur J Clin Nut 67(5):507–512. https://doi.org/10.1038/ejcn.2013.31 CrossRef

13.

Kerns JC, Arundel C, Chawla LS (2015) Thiamin deficiency in people with obesity. Adv Nutr 6(2):147–153. https://doi.org/10.3945/an.114.007526 PubMedPubMedCentralCrossRef

14.

Prado CM, Cushen S, Orsso CE, Ryan AM (2016) Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact. Proc Nutr Soc 75(02):188–198. https://doi.org/10.1017/S0029665115004279 PubMedCrossRef

15.

Batsis JA, Mackenzie T, Lopez-Jimenez F, Bartels SJ (2014) Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III. Eur J Clin Nut 68(9):1001–1007. https://doi.org/10.1038/ejcn.2014.117 CrossRef

16.

Tsai S (2012) Importance of lean body mass in the oncologic patient. Nutr Clin Pract 27(5):593–598. https://doi.org/10.1177/0884533612457949 PubMedCrossRef

17.

Brady MC, Kinn S, Stuart P, Ness V (2003) Preoperative fasting for adults to prevent perioperative complications. Cochrane Database Syst Rev 4. https://doi.org/10.1002/14651858.CD004423

18.

Reddy SK, Barbas A, Turley RS et al (2011) A standard definition of major hepatectomy: resection of four or more liver segments. HPB 13(7):494–502. https://doi.org/10.1111/j.1477-2574.2011.00330.x PubMedPubMedCentralCrossRef

19.

Ciuni R, Biondi A, Grosso G (2011) Nutritional aspects in patient undergoing liver resection. Updat Surg 63(4):249–252. https://doi.org/10.1007/s13304-011-0121-4 CrossRef

20.

Redaelli CA, Wagner M, Krähenbühl L, Gloor B, Schilling MK, Dufour JF, Büchler MW (2002) Liver surgery in the era of tissue-preserving resections: early and late outcome in patients with primary and secondary hepatic tumors. World J Surg 26(9):1126–1132. https://doi.org/10.1007/s00268-002-6321-9 PubMedCrossRef

21.

Veteläinen R, van Vliet A, Gouma DJ, van Gulik TM (2007) Steatosis as a risk factor in liver surgery. Ann Surg 245(1):20–30. https://doi.org/10.1097/01.sla.0000225113.88433.cf PubMedPubMedCentralCrossRef

22.

Fan ST, Lo C, Lai ECS et al (1994) Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med 331(23):1300–1306. https://doi.org/10.1056/NEJM199412083312303 CrossRef

23.

Van den Broek MAJ, Olde Damink S, Dejong CHC et al (2008) Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int 28(6):767–780. https://doi.org/10.1111/j.1478-3231.2008.01777.x PubMedCrossRef

24.

Altekruse SF, Henley S, Cucinelli et al (2014) Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol 109(4):542–553. https://doi.org/10.1038/ajg.2014.11 PubMedPubMedCentralCrossRef

25.

Rahib L, Smith B, Aizenberg R, Rosenweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74(11):2913–2921. https://doi.org/10.1158/0008-5472.CAN-14-0155 PubMedCrossRef

26.

Tang A, Hallouch O, Chernyak V et al (2017) Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. Abdom Radiol. https://doi.org/10.1007/s00261-017-1209-1

27.

White DL, Thrift A, Kanwal F et al (2017) Incidence of hepatocellular carcinoma in all 50 United States from 2000-2012. Gastroenterology 152(4):812–820. https://doi.org/10.1053/j.gastro.2016.11.020 PubMedCrossRef

28.

El-Serag HB, Davila J, Petersen NJ et al (2003) The continuing increase in the incidence of hepatocellular carcinoma. Ann Intern Med 139(10):817–823. https://doi.org/10.7326/0003-4819-139-10-200311180-00009 PubMedCrossRef

29.

Bruix J, Reig M, Sherman M (2016) Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology 150(4):835–853. https://doi.org/10.1053/j.gastro.2015.12.041 PubMedCrossRef

30.

Vitale A, Saracino E, Boccagni P et al (2009) Validation of the BCLC prognostic system in surgical hepatocellular cancer patients. Transpl Proc 41(4):1260–1263. https://doi.org/10.1016/j.transproceed.2009.03.054 CrossRef

31.

Katagiri S, Yamamoto M (2014) Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus. Surg Today 44(2):219–226. https://doi.org/10.1007/s00595-013-0585-6 PubMedCrossRef

32.

Kokudo T, Hasegawa K, Matsuyama Y et al (2016) Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion. J Hepatol 65(5):938–943. https://doi.org/10.1016/j.jhep.2016.05.044 PubMedCrossRef

33.

Lee JM, Jang B, Lee YJ et al (2016) Survival outcomes of hepatic resection compared with transarterial chemoembolization or Sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis. Clin Mol Hepatol 22(16):160–167. 10.18632/oncotarget.8312 PubMedPubMedCentralCrossRef

34.

Cheung K, Lee S, Raman M (2012) Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies. Clin Gastroenterol Hepatol 10(2):117–125. https://doi.org/10.1016/j.cgh.2011.08.016 PubMedCrossRef

35.

Huisman EJ, Trip E, Siersema PD et al (2011) Protein energy malnutrition predicts complications in liver cirrhosis. Eur J Gastroenterol Hepatol 23(11):982–989. https://doi.org/10.1097/MEG.0b013e32834aa4bb PubMedCrossRef

36.

Kalaitzakis E, Simrén M, Olsson R et al (2006) Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life. Scand J Gastroenterol 41(12):1464–1472. https://doi.org/10.1080/00365520600825117 PubMedCrossRef

37.

O’Brien A, Williams R (2008) Nutrition in end-stage liver disease: principles and practice. Gastroenterology 134:1729–1740. https://doi.org/10.1053/j.gastro.2008.02.001 PubMedCrossRef

38.

Kondrup J (2006) Nutrition in end stage liver disease. Best Pract Res Clin Gastroenterol 20(3):547–560. https://doi.org/10.1016/j.bpg.2006.02.001 PubMedCrossRef

39.

Campillo B, Richardet J, Bories PN (2005) Enteral nutrition in severely malnourished and anorectic cirrhotic patients in clinical practice: benefit and prognostic factors. Gastroenterol Clin Biol 29(6-7):645–651. https://doi.org/10.1016/S0399-8320(05)82150-5 PubMedCrossRef

40.

Gunsar F, Raimondo M, Jones S et al (2006) Nutritional status and prognosis in cirrhotic patients. Aliment Pharmacol Ther 24(4):563–572. https://doi.org/10.1111/j.1365-2036.2006.03003.x PubMedCrossRef

41.

Carvalho L, Parise E (2006) Evaluation of nutritional status of nonhospitalized patients with liver cirrhosis. Arq Gasteroenterol 43(4):269–274. https://doi.org/10.1590/S0004-28032006000400005 CrossRef

42.

Guglielmi FW, Panella C, Buda A et al (2006) Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism: multicentre prospective study by the ‘Nutritional Problems in Gastroenterology’ Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis 37(9):681–688. https://doi.org/10.1016/j.dld.2005.03.010 CrossRef

43.

Peng S, Plank L, McCall JL et al (2007) Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study. Am J Clin Nutr 85(5):1257–1266PubMed

44.

Merli M, Nicolini G, Angeloni S et al (2002) Malnutrition is a risk factor in cirrhotic patients undergoing surgery. Nutrition 18(11-12):978–986. https://doi.org/10.1016/S0899-9007(02)00984-X PubMedCrossRef

45.

Muller MJ, Böttcher J, Selberg O (1999) Hypermetabolism in clinically stable patients with liver cirrhosis. Am J Clin Nutr 69(6):1194–1201PubMed

46.

Riggio O, Angeloni S, Ciuffa L et al (2003) Malnutrition is not related to alterations in energy balance in patients with stable liver cirrhosis. Clin Nut 22(6):553–559. https://doi.org/10.1016/S0261-5614(03)00058-X CrossRef

47.

Tsiaousi ET, Hatzitolios A, Trygonis SK et al (2008) Malnutrition in end stage liver disease: recommendations and nutritional support. J Gastroenterol Hepatol 23(4):527–533. https://doi.org/10.1111/j.1440-1746.2008.05369.x PubMedCrossRef

48.

Le Moine O, Marchant A, Groote DD et al (1995) Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholic cirrhosis. Hepatology 22(5):1436–1439. https://doi.org/10.1002/hep.1840220516 PubMedCrossRef

49.

Plauth M, Schütz E (2002) Cachexia in liver cirrhosis. Int J Cardiol 85(1):83–87. https://doi.org/10.1016/S0167-5273(02)00236-X PubMedCrossRef

50.

Marchesini G, Bianchi G, Amodio et al (2001) Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 120(1):170–178. https://doi.org/10.1053/gast.2001.21193 PubMedCrossRef

51.

Owen OE, Reichle F, Mozzoli MA et al (1981) Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis. J Clin Invest 68(1):240–252. https://doi.org/10.1172/JCI110240 PubMedPubMedCentralCrossRef

52.

Owen OE, Trapp V, Reichard GA Jr et al (1983) Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest 72(5):1821–1832. https://doi.org/10.1172/JCI111142 PubMedPubMedCentralCrossRef

53.

Merli M, Leonetti F, Riggio O et al (1999) Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation. Hepatology 30(3):649–654. https://doi.org/10.1002/hep.510300306 PubMedCrossRef

54.

Khanna S, Gopalan S (2007) Role of branched-chain amino acids in liver disease: the evidence for and against. Curr Opin Clin Nut Metab Care 10(3):297–303. https://doi.org/10.1097/MCO.0b013e3280d646b8 CrossRef

55.

Mardini HA, Douglass A, Record C (2006) Amino acid challenge in patients with cirrhosis and control subjects: ammonia, plasma amino acid, and EEG changes. Metab Brain Dis 21(1):1–10. https://doi.org/10.1007/s11011-006-9006-5 PubMedCrossRef

56.

Moscateillo SM, Marchesini G (2007) Diabetes and liver disease: an ominous association. Nutr Metab Cardiovasc Dis 17(1):63–70. https://doi.org/10.1016/j.numecd.2006.08.004 CrossRef

57.

Areth J, Narra S, Nair S (2010) Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 55(9):2624–2628. https://doi.org/10.1007/s10620-009-1069-9 CrossRef

58.

Detsky AS, McLaughlin J, Baker JP et al (1987) What is subjective global assessment of nutritional status? J Parenter Enter Nutr 11(1):8–13. https://doi.org/10.1177/014860718701100108 CrossRef

59.

Henkel AS, Buchman A (2006) Nutritional support in patients with chronic liver disease. Nat Clin Pract Gastroenterol Hepatol 3(4):202–209. https://doi.org/10.1038/ncpgasthep0443 PubMedCrossRef

60.

Huynh DK, Selvanderan S, Harley HAJ et al (2015) Nutritional care in hospitalized patients with chronic liver disease. World J Gasteroenterol 21(11):12835–12842. https://doi.org/10.1097/MEG.0b013e32834aa4bb CrossRef

61.

Plauth M, Cabré E, Riggio O et al (2006) ESPEN guidelines on enteral nutrition: liver disease. Clin Nut 25(2):285–294. https://doi.org/10.1016/j.clnu.2006.01.018 CrossRef

62.

Selberg O, Selberg D (2002) Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis. Eur J Appl Physiol 86(6):509–516. https://doi.org/10.1007/s00421-001-0570-4 PubMedCrossRef

63.

Pinato DJ, North B, Sharma R (2012) A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Cancer 106(8):1439–1445. https://doi.org/10.1038/bjc.2012.92 PubMedPubMedCentralCrossRef

64.

Chan AWH, Chan S, Wong GLH et al (2015) Prognostic nutritional index (PNI) predicts tumor recurrence of very early/early stage hepatocellular carcinoma after surgical resection. Ann Surg Oncol 22(13):4138–4148. https://doi.org/10.1245/s10434-015-4516-1 PubMedCrossRef

65.

Okamura Y, Ashida R, Ito T et al (2015) Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma. World J Surg 39(6):1501–1509. https://doi.org/10.1007/s00268-015-2982-z PubMedCrossRef

66.

Takagi K, Yagi T, Umeda Y (2017) Preoperative controlling nutritional status (CONUT) score for assessment of prognosis following hepatectomy for hepatocellular carcinoma. World J Surg 41(9):2353–2360. https://doi.org/10.1007/s00268-017-3985-8 PubMedCrossRef

67.

Iseki Y, Shibutani M, Maeda K et al (2015) Impact of the preoperative controlling nutritional status (CONUT) score on the survival after curative surgery for colorectal cancer. PLoS One 10(7):e0132488. https://doi.org/10.1371/journal.pone.0132488 PubMedPubMedCentralCrossRef

68.

Ignacio de Ulíbarri J, G-Ma N, de Villar GP et al (2005) CONUT: a tool for controlling nutritional status: first validation in a hospital population. Nutr Hosp 20(1):38–45PubMed

69.

Bolder U, Brune A, Schmidt S et al (1999) Preoperative assessment of mortality risk in hepatic resection by clinical variables: a multivariate analysis. Liver Transpl Surg 5(3):227–237. https://doi.org/10.1002/lt.500050302 PubMedCrossRef

70.

Schütte K, Schuls C, Malfertheiner P (2015) Nutrition and hepatocellular cancer. Gastrointest Tumors 2(4):188–194. https://doi.org/10.1159/000441822 PubMedPubMedCentralCrossRef

71.

Miwa Y, Shiraki M, Kato M et al (2000) Improvement of fuel metabolism by nocturnal energy supplementation in patients with liver cirrhosis. Hepatol Res 18(3):184–189. https://doi.org/10.1016/S1386-6346(99)00100-X PubMedCrossRef

72.

Plank LD, Gane E, Peng S et al (2008) Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial. Hepatology 48(2):557–566. https://doi.org/10.1002/hep.22367 PubMedCrossRef

73.

Matos C, Porayko M, Francisco-Ziller N (2002) Nutrition and chronic liver disease. J Clin Gasteroenterol 35(5):391–397. https://doi.org/10.1097/00004836-200211000-00007 CrossRef

74.

Gluud L, Dam G, Les I, Marchesini G, Borre M, Aagaard N, Vilstrup H (2017) Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev 5. https://doi.org/10.1002/14651858.CD001939.pub4

75.

Morihara D, Iwata K, Hanano T (2012) Late-evening snack with branched-chain amino acids improves liver function after radiofrequency ablation for hepatocellular carcinoma. Hepatol Res 42(7):658–667. https://doi.org/10.1111/j.1872-034X.2012.00969.x PubMedCrossRef

76.

Nishikawa H, Osaki Y, Iguchi E et al (2013) The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency ablation. J Clin Gastroenterol 47(4):359–366. https://doi.org/10.1097/MCG.0b013e31826be9ad PubMedCrossRef

77.

Nishikawa H, Osaki Y, Inuzuka T et al (2012) Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gasteroenterol 18(12):1379–1384. https://doi.org/10.3748/wjg.v18.i12.1379 CrossRef

78.

Ichikawa K, Okabayashi T, Maeda H et al (2012) Oral supplementation of branched-chain amino acids reduces early recurrence after hepatic resection in patients with hepatocellular carcinoma: a prospective study. Surg Today 43(7):720–726. https://doi.org/10.1007/s00595-012-0288-4 PubMedCrossRef

79.

Mikagi K, Kawahara R, Kinoshita H, Aoyagi S (2011) Effect of preoperative immunonutrition in patients undergoing hepatectomy; a randomized controlled trial. Kurume Med J 58:1–8PubMedCrossRef

80.

Rayes N, Seehofer D, Hansen S et al (2002) Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 74(1):123–128. https://doi.org/10.1097/00007890-200207150-00021 PubMedCrossRef

81.

Rayes N, Seehofer D, Theruvath T et al (2005) Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation—a randomized, double-blind trial. Am J Transplant 5(1):125–130. https://doi.org/10.1111/j.1600-6143.2004.00649.x PubMedCrossRef

82.

Usami M, Miyoshi M, Kanbara Y et al (2011) Effects of perioperative synbiotic treatment on infectious complications, intestinal integrity, and fecal flora and organic acids in hepatic surgery with or without cirrhosis. J Parenter Enter Nutr 35(3):317–328. https://doi.org/10.1177/0148607110379813 CrossRef

83.

Kanazawa H, Nagino M, Kamiya S et al (2005) Synbiotics reduce post-operative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbeck's Arch Surg 390(2):104–113. https://doi.org/10.1007/s00423-004-0536-1 CrossRef

84.

Sugawara G, Nagino M, Nishio H et al (2006) Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg 244(5):706–714. https://doi.org/10.1097/01.sla.0000219039.20924.88 PubMedPubMedCentralCrossRef

85.

Richter B, Schmandra T, Golling M, Bechstein WO (2006) Nutritional support after open liver resection: a systematic review. Dig Surg 23(3):139–145. https://doi.org/10.1159/000094345 PubMedCrossRef

86.

Pessaux P, Chenard M, Bachellier P, Jaeck D (2010) Consequences of chemotherapy on resection of colorectal liver metastases. J Visc Surg 147(4):e193–e201. https://doi.org/10.1016/j.jviscsurg.2010.06.004 PubMedCrossRef

87.

Ribeiro HSC, Costa WL Jr, Diniz AL et al (2013) Extended preoperative chemotherapy, extent of liver resection and blood transfusion are predictive factors of liver failure following resection of colorectal liver metastasis. EJSO 39(4):380–385. https://doi.org/10.1016/j.ejso.2012.12.020 PubMedCrossRef

88.

Read JA, Boris Choy S, Beale PJ et al (2006) Evaluation of nutritional and inflammatory status of advanced colorectal cancer patents and its correlation with survival. Nutr Cancer 55(78–85):78–85. https://doi.org/10.1207/s15327914nc5501_10 PubMedCrossRef

89.

Kleiner DE, Brunt E, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6):1313–1321. https://doi.org/10.1002/hep.20701 PubMedCrossRef

90.

Reeves JG, Suriawinata A, Ng DP, Holubar SD, Mills JB, Barth RJ Jr (2013) Short-term preoperative diet modification reduces steatosis and blood loss in patients undergoing liver resection. Surgery 154(5):1031–1037. https://doi.org/10.1016/j.surg.2013.04.012 PubMedCrossRef

91.

Sullivan S (2010) Implications of diet on nonalcoholic fatty liver disease. Curr Opin Gastroenterol 26(2):160–164. https://doi.org/10.1097/MOG.0b013e3283358a58 PubMedPubMedCentralCrossRef

92.

Gholam PM, Flancbaum L, Machan JT, Charney DA, Kotler DP (2017) Nonalcoholic fatty liver disease in severely obese subjects. Am J Gastroenterol 102(2):399–408. https://doi.org/10.1111/j.1572-0241.2006.01041.x CrossRef

93.

de Meijer VE, Kalish B, Pruder M, Ijzermans JNM (2010) Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg 97(9):1331–1339. https://doi.org/10.1002/bjs.7194 PubMedCrossRef

94.

Gomez D, Malik H, Bonney GK, Wong V, Toogood GJ, Lodge JPA, Prasad KR (2007) Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg 94(11):1395–1402. https://doi.org/10.1002/bjs.5820 PubMedCrossRef

95.

Kooby DA, Fong Y, Suriawinata A et al (2003) Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 7(8):1034–1044. https://doi.org/10.1016/j.gassur.2003.09.012 PubMedCrossRef

96.

Zhao J, van Mierlo K, Gómez-Ramírez J et al (2017) Systematic review of the influence of chemotherapy-associated liver injury on outcome after partial hepatectomy for colorectal liver metastases. BJS 104(8):990–1002. https://doi.org/10.1002/bjs.10572 CrossRef

97.

Nomura F, Ohnishi K, Ochiai T, Okuda K (1987) Obesity-related nonalcoholic fatty liver: CT features and follow-up studies after low-calorie diet. Radiology 162(3):845–847. https://doi.org/10.1148/radiology.162.3.3809503 PubMedCrossRef

98.

Fris RJ (2004) Preoperative low energy diet diminishes liver size. Obes Surg 14(9):1165–1170. https://doi.org/10.1381/0960892042386977 PubMedCrossRef

99.

Ryan P, Nanji S, Pollett A, Moore M, Moulton CA, Gallinger S, Guindi M (2010) Chemotherapy-induced liver injury in metastatic colorectal cancer: semiquantitative histologic analysis of 334 resected liver specimens shows that vascular injury but not steatohepatitis is associated with preoperative chemotherapy. Am J Surg Pathol 34(6):784–791. https://doi.org/10.1097/PAS.0b013e3181dc242c PubMedCrossRef

100.

Nakano H, Oussoultzoglou E, Rosso E et al (2008) Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 247(1):118–124. https://doi.org/10.1097/SLA.0b013e31815774de PubMedCrossRef

101.

Vauthey JN, Pawlik T, Ribero D et al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24(13):2065–2072. https://doi.org/10.1200/JCO.2005.05.3074 PubMedCrossRef

102.

Pawlik TM, Olino K, Gleisner A, Torbenson M, Schulick R, Choti MA (2007) Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 11(7):860–868. https://doi.org/10.1007/s11605-007-0149-4 PubMedCrossRef

103.

Wolf PS, Park J, Bao F et al (2013) Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience. J Am Coll Surg 216(1):41–49. https://doi.org/10.1016/j.jamcollsurg.2012.08.030 PubMedCrossRef

104.

Sahajpal A, Vollmer CM Jr, Dixon E et al (2007) Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes. J Surg Oncol 95(1):22–27. https://doi.org/10.1002/jso.20632 PubMedCrossRef

105.

Scoggins CR, Campbell M, Landry CS, Slomiany BA, Woodall CE, McMasters KM, Martin RCG (2009) Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. Ann Surg Oncol 16(1):35–41. https://doi.org/10.1245/s10434-008-0190-x PubMedCrossRef

106.

Karoui M, Penna C, Amin-Hashem M et al (2006) Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243(1):1–7. https://doi.org/10.1097/01.sla.0000193603.26265.c3 PubMedPubMedCentralCrossRef

107.

Kishi Y, Zorzi D, Contreras CM et al (2010) Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol 17(11):2870–2876. https://doi.org/10.1245/s10434-010-1166-1 PubMedCrossRef

108.

Quan D, Gallinger S, Nhan C et al (2012) The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: a systematic review. Surgery 151(6):860–870. https://doi.org/10.1016/j.surg.2011.12.018 PubMedCrossRef

109.

Eriksson S, Eriksson K, Bondesson L (1986) Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand 220(1):83–88. https://doi.org/10.1111/j.0954-6820.1986.tb02733.x PubMedCrossRef

110.

Jones JC, Coombes J, Macdonald GA (2012) Exercise capacity and muscle strength in patients with cirrhosis. Liver Transpl 18(2):146–151. https://doi.org/10.1002/lt.22472 PubMedCrossRef

111.

Bohannon RW, Magasi S, Bubela DJ et al (2012) Grip and knee extension muscle strength reflect a common construct among adults. Muscle Nerve 46(555–558):555–558. https://doi.org/10.1002/mus.23350 PubMedPubMedCentralCrossRef

112.

Campillo B, Fouet P, Bonnet JC et al (1990) Submaximal oxygen consumption in liver cirrhosis: evidence of severe functional aerobic impairment. J Hepatol 10(2):163–167. https://doi.org/10.1016/0168-8278(90)90046-T PubMedCrossRef

113.

Lemyze M, Dharancy S, Wallaert B (2013) Response to exercise in patients with liver cirrhosis: implications for liver transplantation. Dig Liver Dis 45(5):362–366. https://doi.org/10.1016/j.dld.2012.09.022 PubMedCrossRef

114.

Terziyski K, Andonov V, Marinov B et al (2008) Exercise performance and ventilatory efficiency in patients with mild and moderate liver cirrhosis. Clin Exp Pharmacol Physiol 35(0):135–140. https://doi.org/10.1111/j.1440-1681.2007.04751.x PubMed

115.

Weisinger GF, Quittan M, Zimmermann K et al (2001) Physical performance and health-related quality of life in men on a liver transplantation waiting list. J Rehabil Med 33:260–265CrossRef

116.

Epstein SK, Ciubotaru R, Zilberberg MD et al (1998) Analysis of impaired exercise capacity in patients with cirrhosis. Dig Dis Sci 43(8):1701–1707. https://doi.org/10.1023/A:1018867232562 PubMedCrossRef

117.

Pieber K, Crevenna R, Nuhr MJ et al (2006) Aerobic capacity, muscle strength and health-related quality of life before and after orthotopic liver transplantation: preliminary data of an Austrian transplantation centre. J Rehabil Med 38(5):322–328. https://doi.org/10.1080/16501970600680288 PubMedCrossRef

118.

Bernal W, Martin-Mateos R, Lipcsey M et al (2014) Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl 20(1):54–62. https://doi.org/10.1002/lt.23766 PubMedCrossRef

119.

Dharancy S, Lemyze M, Boleslawski E et al (2008) Impact of impaired aerobic capacity on liver transplant candidates. Transplantation 86(8):1077–1083. https://doi.org/10.1097/TP.0b013e318187758b PubMedCrossRef

120.

Andersen H, Borre M, Jakobsen J et al (1998) Decreased muscle strength in patients with alcoholic liver cirrhosis in relation to nutritional status, alcohol abstinence, liver function, and neuropathy. Hepatology 27(5):1200–1206. https://doi.org/10.1002/hep.510270503 PubMedCrossRef

121.

Tartar RE, Panzak G, Switala J et al (1997) Isokinetic muscle strength and its association with neuropsychological capacity in cirrhotic alcoholics. Alcohol Clin Exp Res 21(2):191–196. https://doi.org/10.1111/j.1530-0277.1997.tb03748.x CrossRef

122.

Montano-Loza AJ, Meza-Junco J, Prado CMM (2012) Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 10(2):166–173. https://doi.org/10.1016/j.cgh.2011.08.028 PubMedCrossRef

123.

Ruiz-del-Árbol L, Serradilla R (2015) Cirrhotic cardiomyopathy. World J Gasteroenterol 21(41):11502–11521. https://doi.org/10.3748/wjg.v21.i41.11502 CrossRef

124.

Carey EJ, Steidley D, Aqel BA (2010) Six-minute walk distance predicts mortality in liver transplant candidates. Liver Transpl 16(12):1373–1378. https://doi.org/10.1002/lt.22167 PubMedCrossRef

125.

Tandon P, Low G, Mourtzakis M (2016) A model to identify sarcopenia in patients with cirrhosis. Clin Gastroenterol Hepatol 14(10):1473–1480. https://doi.org/10.1016/j.cgh.2016.04.040 PubMedCrossRef

126.

Zenith L, Meena N, Ramadi A et al (2014) Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis. Clin Gastroenterol Hepatol 12(11):1920–1926. https://doi.org/10.1016/j.cgh.2014.04.016 PubMedCrossRef

127.

Debette-Gratien M, Tabouret T, Antonini MT et al (2014) Personalized adapted physical activity before liver transplantation: acceptability and results. Transplantation 99(1):145–150. https://doi.org/10.1097/TP.0000000000000245 CrossRef

128.

Garcίa-Pagán JC, Santos C, Barberá JA et al (1996) Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology 111(5):1300–1306. https://doi.org/10.1053/gast.1996.v111.pm8898644 CrossRef

129.

Bandi JC, García-Pagán J, Escorsell A et al (1998) Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis. Hepatology 28(3):667–682. https://doi.org/10.1002/hep.510280312 CrossRef

130.

Hulzebos EHJ, Smit Y, Helders PP JM, van Meeteren NLU (2014) Preoperative physical therapy for elective cardiac surgery patients (review). Cochrane Database Syst Rev (11). https://doi.org/10.1002/14651858.CD010118.pub2

131.

Garcia RS, Yáñez-Brage M, Moolhuyzen EG, Riobo MS, Paz AL, Mate JMB (2017) Preoperative exercise training prevents functional decline after lung resection surgery: a randomized, single-blind controlled trial. Clin Rehab 31(8):1057–1067. https://doi.org/10.1177/0269215516684179 CrossRef

132.

Carver TE, Mayo N, Andersen RE, Zavorsky GS (2011) Pilot investigation to evaluate changes in exercise capacity following a prehabilitation intervention among seriously obese patients awaiting bariatric surgery. Can J Diabetes 35(2):149. https://doi.org/10.1016/S1499-2671(11)52045-3 CrossRef

133.

Hijazi Y, Gondal U, Aziz (2017) A systematic review of prehabilitation programs in abdominal cancer surgery. Int J Surg 39:156–162. https://doi.org/10.1016/j.ijsu.2017.01.111 PubMedCrossRef

134.

Dunne DEJ, Jack S, Jones RP et al (2016) Randomized clinical trial of prehabilitation before planned liver resection. Br J Surg 103(5):504–512. https://doi.org/10.1002/bjs.10096 PubMedCrossRef

135.

Mayo NE, Feldman L, Scott S et al (2011) Impact of preoperative change in physical function on postoperative recovery: argument supporting prehabilitation for colorectal surgery. Surgery 150(3):505–514. https://doi.org/10.1016/j.surg.2011.07.045 PubMedCrossRef

136.

Wijeysundera DN, Pearse R, Shulman MA et al (2016) Measurement of Exercise Tolerance before Surgery (METS) study: a protocol for an international multicentre prospective cohort study of cardiopulmonary exercise testing prior to major non-cardiac surgery. BMJ Open 6(3):e010359. https://doi.org/10.1136/bmjopen-2015-010359 PubMedPubMedCentralCrossRef

Titel: Preoperative optimization for major hepatic resection
verfasst von: Sarah Walcott-Sapp
Kevin G. Billingsley
Publikationsdatum: 18.11.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Langenbeck's Archives of Surgery / Ausgabe 1/2018
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI: https://doi.org/10.1007/s00423-017-1638-x

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation

Optimal literature search for systematic reviews in surgery

Statistical approach to quality assessment in liver transplantation

Indication of extrahepatic bile duct resection for gallbladder cancer

Pure laparoscopic anatomical segment VI resection using the Glissonian approach, Rouviere’s sulcus as a landmark, and a modified liver hanging maneuver (with video)

Liver resection for HCC outside the BCLC criteria

Update Chirurgie